A Hartkamp

926 total citations
19 papers, 661 citations indexed

About

A Hartkamp is a scholar working on Physiology, Rheumatology and Immunology. According to data from OpenAlex, A Hartkamp has authored 19 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Rheumatology and 6 papers in Immunology. Recurrent topics in A Hartkamp's work include Salivary Gland Disorders and Functions (8 papers), Systemic Lupus Erythematosus Research (7 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). A Hartkamp is often cited by papers focused on Salivary Gland Disorders and Functions (8 papers), Systemic Lupus Erythematosus Research (7 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). A Hartkamp collaborates with scholars based in Netherlands, United States and Belgium. A Hartkamp's co-authors include Rinie Geenen, G. L. R. Godaert, R. H. W. M. Derksen, Aike A. Kruize, Douwe H. Biesma, A. H. L. Mulder, Heleen van Velzen‐Blad, J. W. J. Bijlsma, Ger T. Rijkers and Henk Visser and has published in prestigious journals such as Annals of the New York Academy of Sciences, Annals of the Rheumatic Diseases and Vaccine.

In The Last Decade

A Hartkamp

19 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Hartkamp Netherlands 14 238 168 140 127 89 19 661
H. H. Peter Germany 13 157 0.7× 203 1.2× 76 0.5× 40 0.3× 72 0.8× 26 536
Mara Felicetti Italy 16 323 1.4× 175 1.0× 104 0.7× 55 0.4× 98 1.1× 53 742
Saverio Naty Italy 14 188 0.8× 76 0.5× 182 1.3× 50 0.4× 43 0.5× 34 607
Marcus Köller Austria 16 304 1.3× 234 1.4× 64 0.5× 29 0.2× 89 1.0× 38 857
Tim Holbrook United Kingdom 9 132 0.6× 142 0.8× 104 0.7× 30 0.2× 41 0.5× 37 643
Andy Abril United States 18 438 1.8× 96 0.6× 163 1.2× 74 0.6× 48 0.5× 62 941
Marleen Nys Belgium 12 245 1.0× 153 0.9× 178 1.3× 27 0.2× 129 1.4× 29 810
Ana Filipa Mourão Portugal 16 534 2.2× 273 1.6× 46 0.3× 74 0.6× 271 3.0× 58 983
Cristian Caimmi Italy 16 384 1.6× 220 1.3× 93 0.7× 26 0.2× 101 1.1× 39 848
Necatı Çakir Türkiye 14 276 1.2× 106 0.6× 36 0.3× 37 0.3× 101 1.1× 31 592

Countries citing papers authored by A Hartkamp

Since Specialization
Citations

This map shows the geographic impact of A Hartkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Hartkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Hartkamp more than expected).

Fields of papers citing papers by A Hartkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Hartkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Hartkamp. The network helps show where A Hartkamp may publish in the future.

Co-authorship network of co-authors of A Hartkamp

This figure shows the co-authorship network connecting the top 25 collaborators of A Hartkamp. A scholar is included among the top collaborators of A Hartkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Hartkamp. A Hartkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kievit, Wietske, Eddy Adang, Herman L. M. Brus, et al.. (2015). Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial. Arthritis Research & Therapy. 17(1). 134–134. 52 indexed citations
2.
Kievit, Wietske, Herman L. M. Brus, Hein J. Bernelot Moens, et al.. (2013). Mode Of Action Change Not Necessary After Failing The First Tumor-necrosisfactor Inhibitor : Preliminary Results Of a Randomized Controlled Trial. Data Archiving and Networked Services (DANS). 65. 4 indexed citations
3.
Fransen, Jaap, Wietske Kievit, Marcel Flendrie, et al.. (2012). Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Annals of the Rheumatic Diseases. 72(6). 895–900. 120 indexed citations
4.
Hartkamp, A, E.R. Bossema, Marc Bijl, et al.. (2012). Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate. Lupus. 21(14). 1515–1521. 7 indexed citations
5.
Hartkamp, A, Rinie Geenen, Aike A. Kruize, et al.. (2011). Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren's syndrome.. PubMed. 29(2). 318–21. 11 indexed citations
6.
Goes, Marlies C. van der, Ercolie R. Bossema, A Hartkamp, et al.. (2010). Cortisol During the Day in Patients with Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome. The Journal of Rheumatology. 38(2). 285–288. 15 indexed citations
7.
Hartkamp, A, et al.. (2010). Variability of fatigue during the day in patients with primary Sjögren's syndrome, systemic lupus erythematosus, and rheumatoid arthritis.. PubMed. 28(5). 715–21. 17 indexed citations
8.
Hartkamp, A, Rinie Geenen, G. L. R. Godaert, et al.. (2009). Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Annals of the Rheumatic Diseases. 69(6). 1144–1147. 35 indexed citations
9.
Hartkamp, A, Rinie Geenen, G. L. R. Godaert, et al.. (2007). Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial. Annals of the Rheumatic Diseases. 67(1). 91–97. 69 indexed citations
10.
Hartkamp, A, Rinie Geenen, Guido L. R. Godaert, et al.. (2006). Dehydroepiandrosterone in primary Sjogren's syndrome: A placebo controlled trial.. Data Archiving and Networked Services (DANS). 54(9). 1 indexed citations
11.
Vriezekolk, Johanna E, Rinie Geenen, A Hartkamp, et al.. (2005). Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren's syndrome.. PubMed. 32(12). 2351–5. 22 indexed citations
12.
Hartkamp, A, Rinie Geenen, Marc Bijl, et al.. (2004). Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 63(10). 1335–1337. 33 indexed citations
13.
Hartkamp, A, Rinie Geenen, G. L. R. Godaert, et al.. (2004). The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus. Arthritis & Rheumatism. 50(11). 3591–3595. 20 indexed citations
14.
Jacobs, E, A Hartkamp, & H. A. H. Kaasjager. (2003). PTU-associated cutaneous vasculitis with ANCA anti-MPO and anti-PR3 antibodies.. PubMed. 61(9). 296–9. 19 indexed citations
15.
Godaert, G. L. R., A Hartkamp, Rinie Geenen, et al.. (2002). Fatigue in Daily Life in Patients with Primary Sjögren's Syndrome and Systemic Lupus Erythematosus. Annals of the New York Academy of Sciences. 966(1). 320–326. 44 indexed citations
16.
Velden, Ankie M.T. van der, A. H. L. Mulder, A Hartkamp, et al.. (2001). Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients. European Journal of Internal Medicine. 12(5). 420–424. 46 indexed citations
17.
Hartkamp, A, A. H. L. Mulder, Ger T. Rijkers, Heleen van Velzen‐Blad, & Douwe H. Biesma. (2001). Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine. 19(13-14). 1671–1677. 91 indexed citations
18.
Hartkamp, A. (2000). Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. The Netherlands Journal of Medicine. 57(6). 215–223. 54 indexed citations
19.
Hartkamp, A, et al.. (1970). 51-chromium labelled human serum albumin placental localisation.. PubMed. 16(5). 106–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. H. Peter Breakdown of academic impact, for papers by Mara Felicetti Breakdown of academic impact, for papers by Saverio Naty Breakdown of academic impact, for papers by Marcus Köller Breakdown of academic impact, for papers by Tim Holbrook Breakdown of academic impact, for papers by Andy Abril Breakdown of academic impact, for papers by Marleen Nys Breakdown of academic impact, for papers by Ana Filipa Mourão Breakdown of academic impact, for papers by Cristian Caimmi Breakdown of academic impact, for papers by Necatı Çakir
Rankless by CCL
2026